Crossmark

Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation

Crossref DOI link: https://doi.org/10.1007/s13311-021-01017-6

Published Print: 2021-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Tavassoly, Omid https://orcid.org/0000-0001-7604-3494
del Cid Pellitero, Esther

Larroquette, Frederique

Cai, Eddie

Thomas, Rhalena A.

Soubannier, Vincent

Luo, Wen

Durcan, Thomas M.

Fon, Edward A.
Funding

Funding for this research was provided by:

W. Garfield Weston Foundation (RR171033)
License Information

Text and Data Mining valid from 2021-04-01

Version of Record valid from 2023-08-18
More Information

This article is maintained by: Elsevier

Article Title: Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-021-01017-6

Content Type: article

Copyright: Copyright © 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.

Document is current

Any future updates will be listed below